JESSICA CHAUMONT: Open Payments
NPI 1982095824 · EUNICE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$411 in 31 payments from 9 companies in 2025. Trend: 2023 $594 · 2024 $516 · 2025 $411
Food & beverage: $411
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $173 |
| Novo Nordisk Inc | 3 | $57 |
| Lilly USA, LLC | 3 | $45 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| Supernus Pharmaceuticals, Inc. | 2 | $33 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
| Alkermes, Inc. | 1 | $16 |
| Ardelyx, Inc. | 1 | $14 |
Products named: VRAYLAR, Wegovy, MOUNJARO, QULIPTA, Auvelity, UBRELVY, Qelbree, FANAPT.
Industry payments across LA — which companies pay providers there.
